Board approves appointment of Akhil Ravi as Head API and Services and Senior Management Personnel
Board approved the appointment of Mr. Akhil Ravi as Head API and Services and Senior Management Personnel, and inducted him as a Member of the Management Council, effective November 13, 2026.
By ScoutQuest · · 2 min read
- Appointment Effective Date
- November 13, 2026
- Role Assigned
- Head API and Services and Senior Management Personnel; Member of the Management Council
- Board Meeting Date
- October 23, 2026
Appointment: the key facts
- The Board of Directors, at its meeting, approved the appointment of Mr. Akhil Ravi as Head API and Services and as Senior Management Personnel of the company.
- He is also inducted as a Member of the Management Council.
- The appointment and induction are effective November 13, 2026.
- The decision followed the recommendation of the Nomination, Governance and Compensation Committee and the Audit Committee.
Who is Mr. Akhil Ravi:
- Nearly 19 years of experience spanning strategy, commercial leadership, business transformation and general management.
- Joined the company in 2018 and currently serves as CEO of Aurigene Pharmaceuticals Services Ltd. (APSL), a wholly owned subsidiary.
- He led APSL's evolution from a start-up-style business into a rapidly scaling CRDMO, with the update citing growth, profitability and capability expansion.
- He led the implementation of Aurigene.ai, an AI-enabled integrated drug discovery workflow that now supports approximately 30% of the drug discovery services business.
- Capability expansion under him covered drug discovery, antibodies, biologics, APIs and peptides.
- Before joining the company, he held sales and transformation roles at McKinsey & Company and ITC, and pursued entrepreneurial ventures in digital sports and health solutions.
- He has a Post-Graduate Programme in Management from the Indian School of Business (ISB) and a B.Tech in Chemical Engineering from IIT Bombay.
Related party link
The update states that Mr. Akhil Ravi is a related party to the company, being the son-in-law of Mr. G V Prasad, Co-Chairman and Managing Director.
Scope of the role
He will continue to be responsible for the operations of Aurigene Pharmaceuticals Services Ltd., a wholly owned subsidiary of the company, alongside the new group-level API and services responsibility.
Revised senior management list
An annexure lists 16 senior management personnel, with Mr. Akhil Ravi added at serial number 15 as Head API and Services. The list continues to show Mr. G V Prasad as Co-Chairman and Managing Director (KMP) and Mr. Erez Israeli as Chief Executive Officer (KMP).
How to read this
This is a senior management appointment disclosure. It tells investors who is accountable for the API and services business and how the senior management council is now composed. An appointment of this nature is a change in who runs a part of the business rather than a statement about company earnings.
Also from Dr Reddys Laboratories
Dr Reddy's files audio and video recordings of October 23, 2026 earnings call on Q2/H1 FY27 results
24 Oct 2026
Auditor's limited review reports with UDIN on Q2 and H1 results
23 Oct 2026
Board meeting outcome: Q2 and H1 FY27 unaudited results approved; Akhil Ravi named Head API and Services
23 Oct 2026
More numbers
- Experience of Mr. Akhil Ravinearly 19 years
- Share of drug discovery services business supported by Aurigene.aiapproximately 30%
- Senior management personnel on the revised list16
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.